Trial intelligence / Profile preview

Liposomal Bupivacaine vs Bupivacaine for Hip Arthroscopy Pain

NCT02947178Phase 4Completed

Sponsor
Walter Reed National Military Medical Center
Start
Mar 2016
Primary completion
Mar 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of liposomal bupivacaine in postoperative pain, sponsored by Walter Reed National Military Medical Center. Primary endpoint: Defense and Veterans Pain Rating Scale at 2 weeks. Started Mar 2016; status: completed.

02

Drugs

liposomal bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT02947178.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02947178.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call